Saturday, November 17, 2018 6:29:52 AM
https://seekingalpha.com/article/4222752-arena-inks-1_2-billion-deal-united-therapeutics
"Arena will be able to negotiate from a position of strength on any potential deal, whether for a drug candidate, a merger, or an outright buyout."
"the key thing to understand with Arena is that it is Etrasimod, not Ralinepag, that is the crown jewel of the pipeline."
"A deal involving Etrasimod or Arena itself could happen at any time..."
"The bottom line is that Arena is poised for something even bigger, and being on the sidelines is getting harder for any investor."
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM